
Pharma
Febo-G 80 (Febuxostat Tablets 80mg)
High-strength xanthine oxidase inhibitor; 80 mg Febuxostat tablets for the chronic management of gout and hyperuricemia.
Febo-G 80 (Febuxostat Tablets 80mg)
Febo-G 80 contains 80 mg of Febuxostat, a potent xanthine oxidase inhibitor used for the chronic management of hyperuricemia in adult patients with gout. It works by reducing the production of uric acid in the body to prevent the formation of urate crystals in the joints. This higher-strength formulation is typically indicated for patients who have not achieved target serum uric acid levels with lower doses. It is not intended for the treatment of acute gout flares, and patients may initially experience an increase in flares when starting therapy. Regular monitoring of liver function and uric acid levels is recommended during treatment.
You May Also Like
Combination DPP-4 inhibitor and Biguanide; 50 mg/500 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/1000 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50mg/500mg Vildagliptin/Metformin tablets for Type 2 Diabetes control.
Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 1000 mg (28 tablets) for Type 2 Diabetes.